Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 4 of 17 for:    Open Studies | estrogen replacement therapy

Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2005 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
National Science Council, Taiwan
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00173550
First received: September 12, 2005
Last updated: January 22, 2007
Last verified: July 2005
  Purpose

The aim of this study is to survey patient’s cognition and attitude about health-related quality of life, use of estrogen, experience of menopausal syndrome, compliance of medication, experience, and satisfaction for women who underwent hysterectomy and bilateral oophorectomy before menopause.


Condition Intervention
Menopause, Premature
Hysterectomy
Ovariectomy
Estrogen Replacement Therapy
Attitude
Perception
Procedure: Hysterectomy and Bilateral salpingo-oophorectomy

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Official Title: Perception and Attitude Toward Estrogen Therapy Among Operated Women With Premature or Immature Menopause

Resource links provided by NLM:


Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 200
Study Start Date: August 2004
Detailed Description:

The cognition and attitude of menopausal women toward hormone replacement could have been changed since the report from WHI in July 2002. Previously, many women used hormone replacement to prevent cardiovascular disease and osteoporosis. Recently, the use has been challenged, exaggerated, and also discussed both in media press and academic meetings. Many women dare not to use them. The women who underwent hysterectomy and bilateral salpingo-oophorectomy before menopause may immediately face the problems caused by deficiency of female sex hormone. For this group of women, as yet there is no conclusion about whether the women should take hormone replacement therapy for a long time to osteoporosis, cardiovascular disease and other chronic disease. The arm for this study from WHI is not closed yet. While the women in our area might have been influenced by this report and have changed their mind. It is essential for us to make a clear understanding about the cognition and attitude for hormone replacement therapy for women who underwent hysterectomy and bilateral salpingo- oophorectomy. Therefore, it may be a pioneer study and worthwhile to do this study. Data from a medical center from 2000 to 2004 will be examined for evidence of bilateral oophorectomy & hysterectomy. The cause for the surgery will be confirmed by pathological findings. These women who were under 50 years of age will be candidate of the study. The women will be interviewed about their beliefs, and cognition, regarding their quality of life and health risks as well as their opinion on menopause and hormone replacement therapy.

  Eligibility

Ages Eligible for Study:   20 Years to 50 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age under 50
  • Hysterectomy and bilateral oophorectomy

Exclusion Criteria:

  • Unwilling to answer the questionnaires
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00173550

Contacts
Contact: Ruey-Jien Chen, MD, PhD 886-2-23123456 ext 5158 rjchen@ha.mc.ntu.edu.tw

Locations
Taiwan
National Taiwan University Hospital Department of Obstetrics and Gynecology Recruiting
Taipei, Taiwan, 100
Contact: Ruey-Jien Chen, MD, PhD    886-2-2312-3456 ext 5158    rjchen@ha.c.ntu.edu.tw   
Principal Investigator: Ruey-Jien Chen, MD, PhD         
Sponsors and Collaborators
National Taiwan University Hospital
National Science Council, Taiwan
Investigators
Principal Investigator: Ruey-Jien Chen, MD, PhD Department or Obstetrics and Gynecology, National Taiwan university Hospital
  More Information

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00173550     History of Changes
Other Study ID Numbers: 9461700710, NSC93-2314-B-002-162
Study First Received: September 12, 2005
Last Updated: January 22, 2007
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
Menopause, premature
Hysterectomy
Ovariectomy
Estrogen Replacement Therapy
Knowledge
Perception
Attitude

Additional relevant MeSH terms:
Estrogens
Menopause, Premature
Primary Ovarian Insufficiency
Adnexal Diseases
Endocrine System Diseases
Genital Diseases, Female
Gonadal Disorders
Ovarian Diseases
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on November 20, 2014